Health TrialsbyHealthPanel

Substance Use Screening to Encourage Behavior Change Among Young People in Primary Care

ConditionsSubstance UseBinge DrinkingCannabis UseAdolescent Behavior
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age14-24
SponsorProf. Dagmar M. Haller

About this trial

This study evaluates whether completing a short screening questionnaire about health behaviours in the waiting room before a primary care consultation decreases excessive substance use in young people aged 14 to 24 years. Young people consulting a primary care physician will randomly receive either a questionnaire about substance use or a questionnaire about physical activity. They will be contacted again 3, 6 and 12 months later and asked to complete a questionnaire about substance use. The proportion of young people with excessive substance use in each group will be compared. The researchers hypothesise that at three months this proportion will be lower in the group of young people having completed the initial questionnaire about substance use when compared to the group having completed the questionnaire about physical activity.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

Acute illness requiring immediate attention of the physician

Severe mental health conditions requiring treatment in a specialized setting

Young person not consulting as a patient at the practice (e.g. accompanying friend or partner)

Inability to read the trial information in French or to provide independent consent.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Substance use questionnaire

    Other intervention

    Screening questionnaire about substance use based on the Detection of Alcohol and Drug Problems in Adolescents (DEP-ADO) survey.

  • Physical activity questionnaire

    Other intervention

    Screening questionnaire about physical activity, based on the short version of the International Physical Activity Questionnaire (IPAQ).

Treatment groups

840 Participants
are divided into 2 treatment groups
Group A: Substance use screeningExperimental treatment 1 intervention
Group B: Physical activity screeningActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Proportion of patients reporting one or more episodes of binge drinking in the past 30 days.

Patient self-report on follow-up telephone questionnaire. Binge drinking is defined as the consumption of five or more standard drinks in one occasion.

Time frame
3 months

Secondary outcomes

1

Proportion of patients reporting smoking one or more cannabis joints per week in the last 30 days.

Patient self-report on follow-up telephone questionnaire.

Time frame
3 months
2

Proportion of patients reporting smoking one or more cannabis joints per week in the last 30 days.

Patient self-report on follow-up telephone questionnaire.

Time frame
6 months
3

Proportion of patients reporting smoking one or more cannabis joints per week in the last 30 days.

Patient self-report on follow-up telephone questionnaire.

Time frame
12 months
4

Proportion of patients reporting smoking at least one cigarette per day in the last 30 days.

Patient self-report on follow-up telephone questionnaire.

Time frame
3 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Prof. Dagmar M. Haller

Lead sponsor

University of Geneva, Switzerland

Sponsor institution

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: